Hemophiliacs can more easily play soccer thanks to this drug? FDA says not so fast

Never mind the hemophilia, a soccer player can still confidently bump into others while hustling downfield thanks to the Idelvion treatment, at least according to CSL Behring promotional materials, anyway.

The drug maker used such an image — specifically, a man who is about to head or kick a soccer ball while jumping high in the air — to promote its hemophilia B medication on its product website and in patient brochures, exhibit panels, and sales aids.

Sounds promising, yes? Not to the Food and Drug Administration, though.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In